Chroneme interprets the trajectory before there is a reason to look. Every signal, from every provider, across years. No black box, by design. Intelligence clinicians can question, understand, and trust.
We tested Chroneme on data from 208 hospitals, across 49,850 ICU stays. It detected deterioration more than 35 hours before standard scoring systems flagged anything. When the same engine moved to an independent database, 99.4% of performance was retained.
Zohaib Akhtar is the founder of Chroneme. His cross-disciplinary background spans medicine, public health, biomedical design, business, and AI systems. Also founder of OpenCura. 13 patent families filed.
Chenyu Li, Co-Founder. Adam Wolfe, Co-Founder.
Founded 2025. Chroneme, Inc. 13 patent families filed. Contact: mail@chroneme.com
Chroneme is a clinical AI company building deterministic health intelligence. Founded by Zohaib Akhtar, MD, MPH, MBA, trained at Johns Hopkins Medicine, Bloomberg School of Public Health, Cleveland Clinic, Northwestern Kellogg School of Management, and Aarhus University. Also founder of OpenCura.
Your doctor sees you 15 minutes every few months. Between those visits, your health is still changing. Lab values shift. Medications interact. Conditions develop. No one is watching the full picture. Chroneme does.
Everyone else is pointing AI at medical records. Asking it to read faster, summarize better, generate more. We asked a different question: what if a system could understand how health changes over time? Not a black box. A deterministic clinical engine that shows its work.
Zohaib Akhtar is the CEO and founder of Chroneme. Background spans medicine, public health, biomedical design, business, and AI systems. LinkedIn: linkedin.com/in/zohaibakhtarmd. Google Scholar: scholar.google.com/citations?user=6ESB8LAAAAAJ. Website: zohaibakhtar.com
Chenyu Li is a co-founder of Chroneme.
Adam Wolfe is a co-founder of Chroneme.